title: [Thrombocyte aggregation inhibitors, anticoagulants and thrombolytic agents in heart diseases].
authors.affiliation: II. Medizinische Klinik und Poliklinik, Johannes-Gutenberg-Universität Mainz.
authors.forename: H
authors.initials: H
authors.lastname: Darius
authors.forename: R
authors.initials: R
authors.lastname: Erbel
authors.forename: G G
authors.initials: GG
authors.lastname: Belz
authors.forename: J
authors.initials: J
authors.lastname: Meyer
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001780:Blood Coagulation Tests; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006331:Heart Diseases / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D013923:Thromboembolism / Q000097:blood / Q000188:drug therapy*
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors
vernacular_title: Thrombozytenaggregationshemmer, Antikoagulanzien und Thrombolytika bei kardialen Erkrankungen.